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Abstract
Introduction: The role of ICU design and particularly single-patient rooms in decreasing bacterial transmission
between ICU patients has been debated. A recent change in our ICU allowed further investigation.
Methods: Pre-move ICU-A and pre-move ICU-B were open-plan units. In March 2007, ICU-A moved to single-
patient rooms (post-move ICU-A). ICU-B remained unchanged (post-move ICU-B). The same physicians cover both
ICUs. Cultures of specified resistant organisms in surveillance or clinical cultures from consecutive patients staying
>48 hours were compared for the different ICUs and periods to assess the effect of ICU design on acquisition of
resistant organisms.
Results: Data were collected for 62, 62, 44 and 39 patients from pre-move ICU-A, post-move ICU-A, pre-move ICU-
B and post-move ICU-B, respectively. Fewer post-move ICU-A patients acquired resistant organisms (3/62, 5%)
compared with post-move ICU-B patients (7/39, 18%; P = 0.043, P = 0.011 using survival analysis) or pre-move ICU-
A patients (14/62, 23%; P = 0.004, P = 0.012 on survival analysis). Only the admission period was significant for
acquisition of resistant organisms comparing pre-move ICU-A with post-move ICU-A (hazard ratio = 5.18, 95%
confidence interval = 1.03 to 16.06; P = 0.025). More antibiotic-free days were recorded in post-move ICU-A
(median = 3, interquartile range = 0 to 5) versus post-move ICU-B (median = 0, interquartile range = 0 to 4; P =
0.070) or pre-move ICU-A (median = 0, interquartile range = 0 to 4; P = 0.017). Adequate hand hygiene was
observed on 140/242 (58%) occasions in post-move ICU-A versus 23/66 (35%) occasions in post-move ICU-B (P <
0.001).
Conclusions: Improved ICU design, and particularly use of single-patient rooms, decreases acquisition of resistant
bacteria and antibiotic use. This observation should be considered in future ICU design.
Introduction
The Centers for Disease Control estimate that annually
in the US approximately 1.7 million patients suffer from
hospital-acquired infections with 99,000 deaths [1] and a
cost of up to $33.8 billion [2]. About 20% of ICU
patients will develop nosocomial infections, often caused
by resistant bacteria [3,4], and many more become colo-
nized by resistant bacteria [4,5].
Bacteria are transmitted between ICU patients by
direct contact (principally via caregivers’ hands), droplets
(for example, from infected airway secretions) and via
fomites (inanimate objects in the ICU environment)
[6,7]. Improved ICU architecture might limit the spread
of bacteria. Single-patient rooms, for example, have
been in use for almost a century [8] despite equivocal
evidence [9].
A recent upgrade to one of our ICUs presented the
opportunity to test the effect of improved architecture
on acquisition of resistant bacteria. Prior to the upgrade,
the ICUs were both open plan and existed in two sepa-
rate locations. In March 2007, one location was refur-
bished, with each bed being placed in a separate closed
room, while the other ICU remained unchanged. This
situation presented the opportunity to compare the
acquisition rates of resistant bacteria between patients
admitted to a single-room ICU and to an open-plan
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tion location and the open-plan ICU acting as a control
environment.
Materials and methods
Study design
The study was performed in the general ICU of the
Hadassah Hebrew University Medical Center, Jerusalem,
Israel, a 750-bed urban academic tertiary referral center.
The ICU exists in two separate locations. Prior to
March 2007 these two sites were open plan (ICU-A,
seven open-plan beds; ICU-B, four beds with dividers).
In March 2007 ICU-A moved to a new location with
eight beds each in a separate closed room, while ICU-B
remained unchanged (Figure 1). Patient location is
determined by space availability. Each ICU had a sepa-
rate nursing staff, but patients were treated by the same
team of physicians.
Data were collected prospectively from all patients
admitted for longer than 48 hours. July 2005 to January
2006 comprised the pre-move period, while October
2007 to February 2008 was the post-move period.
Patients transferred from ICU-A to ICU-B or vice versa
and ICU patients admitted to the post-anesthesia recov-
ery unit were excluded. The Hadassah Hebrew Univer-
sity Medical Center ethics committee approved the
study (number 1-20/05/01) and waived any requirement
for informed consent prior to data collection.
All patients were treated with standard infection con-
trol precautions. Alcohol-based hand rub was freely
available next to each bed pre-move and next to each
bed or at the entrance to each room post-move (Figure
1). In post-move ICU-A, each room had its own sink,
alcohol-based hand rub dispenser, computer and basic
medical supplies (syringes, needles, suction equipment,
and so forth). In pre-move ICU-A and in both pre-move
and post-move ICU-B, computers and sinks were shared
and medical equipment was available on carts common
to all patients. The nurse to patient ratio was 1:2 in
both ICUs and at both time points.
Data collection included the ICU and period of admis-
sion, demographics, admission functional status (defined
as functionally independent or not), outcome, Acute
Physiology and Chronic Health Evaluation II score (for
first 24 hours) [10], antibiotic administration, occurrence
of nosocomial infection and results of all microbiological
studies (both surveillance and clinical).
Nosocomial acquisition of resistant bacteria
Data were collected on methicillin-resistant Staphylococ-
cus aureus (MRSA), vancomycin-resistant enterococci,
Acinetobacter baumannii resistant to ceftazidime, carba-
penem-resistant Enterobacteriaceae, and extended-spec-
trum b-lactamase-producing Enterobacteriaceae (defined
as Enterobacteriaceae resistant to ceftazidime). Surveil-
lance cultures (from the nose, axilla and perineum) were
performed sporadically in the pre-move ICUs and on
I C Ua d m i s s i o na n do n c ew e e k l yi nb o t hI C U sd u r i n g
the post-move period. Surveillance was performed for
MRSA, vancomycin-resistant enterococci, carbapenem-
resistant Enterobacteriaceae and A. baumannii.
Hospital cultures performed during the 6 months
prior to ICU admission were also assessed. A positive
culture for one of the index bacteria during the 6
months prior to ICU admission or during the first 48
hours of ICU admission defined the patient as colonized
on admission. A positive culture appearing after the first
48 hours or up to 48 hours after ICU discharge indi-
cated colonization/infection that occurred during the
ICU stay. Patients who were colonized/infected with any
of the defined resistant bacteria on ICU admission could
not become colonized/infected with that bacterial spe-
cies during their ICU stay and were excluded from ana-
lysis regarding the risk of acquiring the specific resistant
bacteria in the ICU. Acquisition of other resistant bac-
teria remained possible.
A composite measure representing colonization/infec-
tion by any of the index bacteria was defined as follows.
A patient in whom any of the defined organisms were
cultured within 48 hours of ICU admission met the cri-
t e r i af o rt h ec o m p o s i t em e a s u r eo fa n yr e s i s t a n to r g a n -
ism on admission. A patient for whom any of the
defined organisms were discovered in cultures taken
after 48 hours in the ICU, and who was not infected/
colonized with the specific organism on admission, met
the criteria for the composite measure of ICU acquisi-
tion of any resistant organism.
Hand hygiene compliance
Hand hygiene compliance was observed covertly by a sin-
gle trained observer during the post-move period based
on criteria defined by the World Health Organization
five moments of hand hygiene [11]. Hand hygiene obser-
vations were performed during office hours and data
were collected separately for physicians and nurses. Data
were collected on at least 40 hand hygiene opportunities
per month per ICU. Adequate hand hygiene was consid-
ered use of either alcohol hand rub or 4% chlorhexidine
soap and water. The proportion of the total number of
observed hand hygiene opportunities where adequate
hand hygiene was performed was recorded.
Antibiotic use
Use of all antibiotics was recorded. To detect a possible
decrease in antibiotic usage, the median number (plus
interquartile range) of antibiotic-free days for ICU-A
and ICU-B before and after the ICU-A move was calcu-
lated and compared.
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The presence of nosocomial bloodstream infections,
pneumonia or urinary tract infection was recorded
based on Centers for Disease Control definitions [12].
The presence of nosocomial infection was determined
prospectively throughout the study by a dedicated study
nurse/physician based on real-time review of chest X-
ray scans, blood and urine cultures, and the patients’
Pre Move ICU A. 8 physical spaces, 
7 used. Possibility of  1 single 
patient room.
Post Move ICU A. 9 single patient 
physical spaces, 8 used. 
ICU B. Unchanged through 
study periods. 5 physical 
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Page 3 of 9clinical courses. Training and an occasional audit were
performed by the principal investigators. Borderline
cases and uncertainty were also resolved by the principal
investigators. The proportion of patients developing one
of these infections after the first 48 hours in the ICU
was compared.
Data analysis
The primary hypothesis was that admission to post-
move ICU-A decreased the risk of an individual patient
acquiring resistant bacteria in the ICU. To test this
hypothesis, the proportion of patients acquiring defined
resistant bacteria was compared across the different
ICUs and time periods. The primary comparison was
between post-move ICU-A and post-move ICU-B, repre-
senting the intervention and contemporary control
groups. Comparisons were also performed between
post-move ICU-A and pre-move ICU-A (to demonstrate
a change over time), between pre-move ICU-A and pre-
move ICU-B (to ascertain similarity), and finally
between pre-move ICU-B and post-move ICU-B (to
demonstrate consistency).
Risk for acquisition of resistant organisms is partly
dependent on colonization pressure [13-15]. The total
number of patient-days during which an uninfected/
uncolonized patient was exposed to other patients who
were infected/colonized with a resistant organism was
therefore calculated. This figure represented the coloni-
zation pressure to which each individual patient was
subjected. For example, Patient X is a new patient unco-
lonized with resistant organisms who has been admitted
to the ICU for 5 days. A culture taken on day 5 is posi-
tive for a resistant organism. During the 5 days prior to
t h ed i s c o v e r yo far e s i s t a n to r g a n i s mt h e r ew e r et h r e e
other patients present in the ICU with a resistant organ-
ism. Patient X was therefore exposed to a colonization
pressure of 5 × 3 = 15.
T h er i s ko fa c q u i r i n gar e s i s t a n to r g a n i s mw a se x a m -
ined using univariate analysis and multivariate Cox
regression analysis. Variables from the univariate analy-
sis were included in the multivariate analysis if signifi-
cant at P ≤0.05. Proportions were compared using the
c h i - s q u a r e dt e s to rP e a r s o n ’s exact test. Normally dis-
tributed continuous variables were compared using Stu-
dent’s t test; otherwise, the Wilcoxon test was used.
Data collection periods were determined by available
resources. Statistical significance was defined as two-
tailed P < 0.05. SAS version 8.02 (SAS Corporation,
Cary, NC, USA) was used for all data analysis.
Results
Data were collected for 207 patients, including 62 pre-
move ICU-A patients, 62 post-move ICU-A patients, 44
pre-move ICU-B patients and 39 post-move ICU-B
patients. An additional 33 ICU patients were excluded
due to admission to the post-anesthesia care unit (eight
prior to the ICU move and 12 following the move) or
transfer between ICU-A and ICU-B (four before the
move, nine after). Demographics, medical history and
outcome data are shown in Table 1.
The ICU admission prevalence and the ICU acquisi-
tion of resistant bacteria are shown in Table 2. Overall,
the admission prevalence of resistant bacteria was higher
in the pre-move ICUs versus the post-move ICUs: 38/
106 patients (36%, 95% confidence interval (CI) = 27 to
45%) versus 18/101 patients (18%, 95% CI = 10 to 25%)
(P = 0.004). The time course for acquisition of resistant
organisms is shown in Figure 2 and is analyzed below.
Principal comparison: post-move ICU-A versus post-move
ICU-B
The patient populations in the single-room post-move
ICU-A and the contemporary open-plan post-move
ICU-B were similar, with no demographic or past medi-
cal history variables being significantly different. The
admission prevalence of resistant bacteria was equal
between the two ICUs.
Significantly fewer post-move ICU-A patients (3/62,
5%; 95% CI = 0 to 10%) acquired a resistant organism
during their ICU stay when compared with post-move
ICU-B patients (7/39, 18%; 95% CI = 6 to 30%; P =
0.043), representing a decrease of 72%. This was con-
firmed using time-course analysis (P = 0.011) and
occurred despite a higher colonization pressure in post-
move ICU-A (8.5 ± 11 vs. 5.2 ± 6 days/patient, P =
0.052). Using multivariate Cox regression (including
colonization pressure and ICU of admission), only the
admitting ICU was a significant predictor for acquisition
of resistant organisms (post-move ICU-B vs. post-move
ICU-A: hazard ratio = 4.07, 95% CI = 1.03 to 16.1; P =
0.045). There was also a trend to more antibiotic-free
days in post-move ICU-A (median = 3, interquartile
range (IQR) = 0 to 5 vs. median = 0, IQR = 0 to 4; P =
0.070).
Regarding hand hygiene practice, physicians (who cov-
ered both ICUs) were compliant on 140/242 occasions
(58%, 95% CI = 52 to 64%) in post-move ICU-A versus
23/66 occasions (35%, 95% CI = 23 to 46%) in post-
move ICU-B (P < 0.001). Nurses, however, complied on
129/188 occasions (69%, 95% CI = 62 to 75%) in post-
move ICU-A versus 118/206 occasions (57%, 95% CI =
50 to 64%) in post-move ICU-B (P = 0.020).
Assessing change: post-move ICU-A versus pre-move ICU-
A
Significantly fewer post-move ICU-A patients acquired a
resistant organism compared with pre-move ICU-A
patients (3/62, 5%; 95% CI = 0 to 10% vs. 14/62, 23%;
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course analysis) (Figure 2). There were significantly
more antibiotic-free days in post-move ICU-A (median
= 3, IQR = 0 to 5 vs. median = 0, IQR = 0 to 4 for pre-
move ICU-A; P = 0.017).
The Acute Physiology and Chronic Health Evaluation
II score, antibiotic therapy prior to ICU admission, hos-
pital admission prior to ICU admission and prevalence
of resistant bacteria on ICU admission were significantly
higher or more frequent in pre-move ICU-A. Only the
ICU of admission was a significant predictor of acquisi-
tion of a resistant organism on multivariate analysis
(pre-move ICU-A vs. post-move ICU-A: OR 5.18, 95%
CI = 1.03 to 16.06; P = 0.025). Colonization pressure
was also higher in pre-move ICU-A (11.4 ± 22 vs. 8.5 ±
11 for post-move ICU-A), but the difference did not
reach statistical significance (P =0 . 3 6 2 )a n dw a st h e r e -
fore not included in the multivariate analysis.
Baseline comparison: pre-move ICU-A versus pre-move
ICU-B
These patient populations were similar with the excep-
tion that surgery prior to ICU admission was more com-
mon and preadmission antibiotic use less frequent in
pre-move ICU-B patients (Table 1). There were no sig-
nificant differences in the admission prevalence or ICU
acquisition of resistant bacteria (Table 1 and Figure 2; P
= 0.615). The number of antibiotic-free days was equiva-
lent (pre-move ICU-A vs. pre-move ICU-B: median anti-
biotic-free days = 0, IQR = 0 to 4 vs. median = 1, IQR =
0t o3 ;P = 0.515).
Consistency: pre-move ICU-B versus post-move ICU-B
There were no differences in patient population, acquisi-
tion of resistant bacteria (post-move ICU-B vs. pre-move
ICU-B patients: 7/39, 18%; 95% CI = 6 to 30% vs. 9/44,
20%; 95% CI = 8 to 32%; P = 0.773, P = 0.347 by time-
Table 1 Admission and outcome variables
Pre-A
(n = 62)
Pre-B
(n = 44)
Post-A
(n = 62)
Post-B
(n = 39)
Pre-A vs.
pre-B
Post-A vs.
post-B
Pre-A vs.
post-A
Pre-B vs.
post-B
Demographics
Age (years) 57 ± 24 59 ± 22 57 ± 23 53 ± 24 0.609 0.418 0.939 0.242
Gender (male) 36 (58) 29 (66) 40 (65) 32 (82) 0.414 0.058 0.461 0.096
APACHE II score 21 ± 9 19 ± 8 18 ± 9 17 ± 8 0.144 0.684 0.028 0.321
Pre-hospital functionally
independent
45 (73) 33 (75) 47 (76) 32 (82) 0.781 0.621 0.682 0.437
Antibiotic therapy prior to ICU
admission (days)
37 (60) 16 (36) 20 (32) 18 (46) 0.008 0.161 0.001 0.365
Hospital admission prior to ICU
admission (days)
37 (60) 23 (62) 21 (34) 20 (51) 0.449 0.083 0.004 0.928
Trauma ICU admission etiology 14 (23) 8 (18) 16 (26) 9 (23) 0.582 0.757 0.675 0.581
Surgery prior to ICU admission 25 (40) 29 (66) 24 (39) 22 (56) 0.009 0.082 0.854 0.375
Past medical history
Ischemic heart disease
a 9 (15) 2 (5) 4 (6) 1 (3) 0.117 0.646 0.143 1.000
Respiratory disease
a 2 (3) 0 (0) 2 (3) 0 (0) 0.510 0.521 1.000 -
Diabetes mellitus 17 (27) 16 (36) 9 (15) 11 (28) 0.327 0.093 0.078 0.773
Chronic steroid use 8 (13) 5 (11) 4 (6) 4 (10) 0.812 0.491 0.224 1.000
Cirrhosis
a 3 (5) 2 (5) 4 (6) 1 (3) 0.944 0.381 1.000 1.000
Chronic dialysis
a 4 (6) 1 (2) 2 (3) 2 (5) 0.400 0.639 0.677 0.598
Solid organ transplant 1 (2) 0 (0) 3 (5) 1 (3) 1.000 1.000 0.619 0.470
Immunosuppressed
a 3 (5) 2 (5) 4 (6) 4 (10) 1.000 0.707 1.000 0.412
Malignant disease 16 (26) 9 (20) 12 (19) 6 (15) 0.523 0.791 0.390 0.549
Colonization pressure (mean daily) 11.4 ±
22.2
10.0 ± 14.9 8.5 ± 11 5.2 ± 6 0.706 0.052 0.362 0.052
Outcomes
Do-not-resuscitate order given 7 (11) 5 (11) 7 (11) 1 (3) 1.000 0.147 1.000 0.207
ICU length of stay (days) 8.5 (5 to
15)
11 (5 to
16)
8( 4t o
15)
7( 4t o
14)
0.662 0.477 0.442 0.065
Hospital length of stay (days) 25 (16 to
47)
32.5 (16 to
50)
26 (16 to
42)
27 (15 to
45)
0.600 0.878 0.677 0.350
ICU mortality 10 (16) 5 (11) 10 (16) 6 (15) 0.488 1.000 1.000 0.590
Data presented as mean ± standard deviation, n (%), n (interquartile range) or P value. Pre-A, pre-move ICU-A; pre-B, pre-move ICU-B; post-A, post-move ICU-A;
post-B, post-move ICU-B.
aAs defined in the Acute Physiology and Chronic Health Evaluation (APACHE) II score [10].
Levin et al. Critical Care 2011, 15:R211
http://ccforum.com/content/15/5/R211
Page 5 of 9Table 2 Prevalence of resistant bacteria on admission and incidence of resistant bacteria acquisition during ICU stay
Pre-A Pre-B Pre-A vs. pre-B Post-A Post-B Post-A vs. post-B
Prevalence of resistant bacteria on admission
Acinetobacter baumannii
a 11/62 (18) 6/44 (14) 0.570 5/62 (8) 1/39 (3) 0.401
Carbapenem-resistant Enterobacteriaceae 0/62 (0) 0/44 (0) - 4/62 (6) 1/39 (3) 0.646
ESBL Enterobacteriaceae
a 11/62 (18) 6/44 (14) 0.570 8/62 (13) 3/39 (8) 0.523
MRSA 5/62 (8) 4/44 (9) 1.000 2/62 (3) 0/39 (0) 0.521
VRE 5/62 (8) 1/44 (2) 0.397 0/62 (0) 3/39 (8) 0.055
Any resistant organism 25/62 (40) 13/44 (30) 0.253 11/62 (18) 7/39 (18) 0.979
Acquisition of resistant bacteria during ICU stay
Acinetobacter baumannii
a 8/51 (16) 5/38 (13) 0.738 1/57 (2) 3/38 (8) 0.298
Carbapenem-resistant Enterobacteriaceae 0/62 (0) 1/44 (2) 0.415 0/58 (0) 2/38 (5) 0.154
ESBL Enterobacteriaceae
a 4/51 (8) 2/38 (5) 1.000 1/54 (2) 0/36 (0) 1.000
MRSA 3/57 (5) 2/40 (5) 1.000 0/60 (0) 3/39 (8) 0.058
VRE 1/57 (2) 0/43 (0) 1.000 1/62 (2) 0/36 (0) 1.000
Any resistant organism 14/62 (23) 9/44 (20) 0.794 3/62 (5) 7/39 (18) 0.043
Data presented as number of positive patients/patients at risk (%) or P value. The denominator for admission prevalence is the total number of study patients
included. The denominator for ICU acquisition is determined by number of included patients minus patients with resistant bacteria on admission. As no patients
were colonized/infected with all five resistant organisms on admission, the denominator for ICU acquisition of any of the resistant organisms remained
equivalent to the total study population. ESBL, extended spectrum b-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant
enterococci. pre-A, pre-move ICU-A; pre-B, pre-move ICU-B; post-A, post-move ICU-A; post-B, post-move ICU-B;.
aResistant to at least ceftazidime.
Figure 2 Time course for acquisition of resistant organisms in the ICU.
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move ICU-B vs. pre-move ICU-B: median = 0, IQR = 0
to 4 vs. median = 1, IQR = 0 to 3; P = 0.717), although
the colonization pressure was nonsignificantly higher in
pre-move ICU-B (Table 1).
Nosocomial infections
The proportions of patients who developed nosocomial
bloodstream infections, pneumonia or urinary tract
infection over the study periods are shown in Table 3.
Overall there was a decrease in the occurrence of noso-
comial infections from the pre-move to post-move peri-
ods. However, there was no difference in the incidence
rate when comparing ICU-A with ICU-B within each
time period.
Discussion
Improved ICU architecture, including a change to single
rooms, led to a statistically and clinically significant 72%
decrease in the risk of acquiring resistant bacteria and a
decrease in antibiotic usage. The strength of these find-
ings lies in the comparison of patients admitted at the
same time to two separate ICU environments, one open
plan and the other single rooms, and treated by the
same physician team. These findings have important
implications for future ICU design.
The precise element of the design change that con-
tributed to the decrease in acquisition of resistant bac-
teria cannot be determined, as the design change
included many elements - single rooms, increased
patient area, increased number of sinks per patient, and
so forth. Each of these individual elements may have
contributed to improved infection control [16]. Further,
hand hygiene compliance (particularly by physicians)
was higher in the single-room ICU, possibly indicating
that ICU design may have an effect on staff behavior
and not only on the physical environment.
Investigating the effect of ICU design on acquisition of
resistant bacteria is methodologically difficult. Costs pre-
vent ICUs from being constructed for research purposes
only, and alterations in ICU design involve a range of
structural changes that could affect spread of resistant
bacteria. Further, most studies examining the effect of
changes in ICU design are of a before/after design, or
are performed in the context of an outbreak of resistant
organisms and involve multiple infection control mea-
sures, meaning that the contribution of ICU design
alone is impossible to determine [9]. As before/after stu-
dies are conducted over long time periods, the effects of
general environmental (for example, antibiotic flora) and
educational (for example, infection control awareness)
changes are also difficult to account for. The current
study collected contemporary data in parallel from two
branches of the same ICU covered by the same physi-
cian. This comparison counteracted many of these lim-
itations and allowed investigation of the effect of change
in ICU design in isolation.
Two recent studies have addressed the issue of single-
patient ICU rooms: a Canadian observational trial of an
ICU move that led to a decrease of approximately 50%
in ICU acquisition of certain organisms [17], and an
interventional interrupted time-series study examining
the ICU spread of MRSA that showed no benefit from
isolation rooms [18]. In the MRSA study, patients were
transferred to isolation rooms only after identification of
MRSA (a process taking approximately 3 days), the sin-
gle rooms were within an open-plan ICU (rather than a
unit comprising single rooms only), and hand hygiene
practices did not change over the study period [18].
Both our study and the Canadian observational study
[17] addressed these issues. Patients were admitted to
single rooms at the outset, potentially protecting them
from colonization with resistant bacteria from other
undetected carriers. Second, the study ICUs comprised
exclusively single rooms, reducing patient exposure to
equipment common to multiple patients. Inanimate
objects (such as computer equipment, sink faucets, beds
and chairs) become colonized with resistant bacteria
[19-21] and have been implicated in their transfer
between patients [22]. The use of single rooms within
an open-plan unit might thus be inadequate as the
environment around the single room might still remain
a reservoir for transmission of bacteria, while separation
of patients and their equipment may provide additional
benefit. Third, our study suggests that the effect of ICU
design may be mediated in part by behavioral change.
Hand hygiene for the same physician team was better in
the single-room ICU than in the open-plan ICU. This
Table 3 Comparison of nosocomial infection rates for pre-move and post-move ICU-A and pre-move and post-move
ICU-B
Pre-A
(n = 62)
Pre-B
(n = 44)
Post-A
(n = 62)
Post-B
(n = 39)
Pre-A vs. pre-B Post-A vs. post-B Pre-A vs. post-A Pre-B vs. post-B
Pneumonia 13 (21) 12 (27) 5 (8) 5 (13) 0.45 0.50 0.04 0.12
Bacteremia 14 (23) 13 (13) 7 (11) 3 (8) 0.42 0.74 0.09 0.01
UTI 7 (11) 3 (7) 8 (13) 1 (3) 0.52 0.15 0.78 0.62
Data presented as n (%) or P value. Pre-A, pre-move ICU-A; pre-B, pre-move ICU-B; post-A, post-move ICU-A; post-B, post-move ICU-B; UTI, urinary tract infection.
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and suggests that ICU design has effects beyond the
ergonomic fostering improved infection control aware-
ness, once again potentially limiting the effectiveness of
patient isolation within an open-plan unit.
The present study has several limitations. First, the
study was small, had a short follow-up period and did
not show an effect on mortality or ICU length of stay.
Second, routine surveillance for resistant bacteria was
performed only in the post-move ICUs, which might be
seen as a confounder in the comparison of the pre-
move and post-move ICUs. However, the main outcome
measure was a comparison of post-move ICU-A with
the control patients in post-move ICU-B, where equiva-
lent surveillance culturing was performed. Further,
increased surveillance culturing would be expected to
increase detection of resistant bacteria. Despite this,
acquisition in post-move ICU-A was lower than that in
pre-move ICU-A, strengthening the study findings. The
changes found over time in fact emphasize the necessity
for contemporary controls when assessing infection con-
trol interventions. Finally, patient distribution between
the two ICUs was not truly random. However, as it was
rare that more than one ICU bed was available at a spe-
cific time, allocation of the bed location was not deter-
mined by physician preference, but rather by availability.
Further, the admission prevalence of resistant bacteria
was no different when comparing pre-move ICU-A to
pre-move ICU-B or post-move ICU-A to post-move
ICU-B.
The American Institute of Architects recommends
single-patient rooms in their guidelines for hospital
design [23], while in France single-patient rooms have
been required in all new hospitals constructed over the
past 20 years [24]. These interventions cost millions of
dollars. Despite this cost, data supporting the use of sin-
gle-patient rooms have been limited. Our study contri-
butes a high-quality, quasi-experimental comparison of
open-space versus single-room ICU accommodation and
shows that improved ICU design reduces the acquisition
of resistant bacteria and use of antibiotics.
Conclusions
The use of single rooms to prevent cross-infection/colo-
nization between ICU patients is common but expensive
and unproven. This investigation compared acquisition
of resistant bacteria and antibiotic use between ICU
patients admitted to single rooms and contemporary
patients admitted to a open-plan ICU. The study
showed a 72% decrease in colonization/infection by
resistant bacteria for patients in single rooms and an
increase in antibiotic-free days. The present study may
influence the way ICUs are designed in the future.
Key messages
￿ This is a prospective observational examination of
the effect of ICU design on the acquisition of resis-
tant bacteria including patients in a single-room ICU
and comparing them with patients admitted at the
same time to an open-plan ICU, both ICUs being
treated by the same physician team.
￿ The improved ICU design (principally the use of
single-patient rooms) significantly decreased acquisi-
tion of antibiotic-resistant bacteria by 72%.
￿ This change also led to an increased number of
antibiotic-free days.
￿ Whether the decreased acquisition of bacteria
resulted from the physical change in ICU design
itself or reflected an effect of ICU design on staff
conduct (through increased hand hygiene, for exam-
ple) could not be determined.
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